About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3614558
Allelic
Composition
Tg(CD2-Tgfbr2)1Grs/0
Genetic
Background
C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CD2-Tgfbr2)1Grs mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• by 12-24 weeks of age, CD8+ numbers begin to rise in transgenic mice such that eventually cells from the spleen and lymph nodes (LN) of transgenic mice contain up to 10-fold the numbers of CD8+ T cells seen in splenocytes and LN cells of control mice, whereas absolute numbers of splenic and LN CD4+ T cells and of B cells in transgenic mice are similar to or lower than in control mice
• the CD4+/CD8+ T cell ratio of transgenic mice between 12 and 24 weeks of age becomes severely skewed in favor of CD8+ T cells due to the expansion of CD8+ cells
• a significantly higher proportion of lymph node T cells is cycling in transgenic than in littermate control mice
• the proportion of peripheral CD8+ T cells that are acively cycling in transgenic mice reaches the level (5-8%) seen in thymi of both transgenic and wild-type mice
• over time, the expanded CD8+ T cell population in transgenic mice progresses from polyclonal to oligoclonal - representing several clonal lineages - to, by 6-12 months of age, monoclonal or biclonal, based on the T cell beta variable region (TCR-Vb) repertoire of the population
• moderate infiltration of the heart, liver and lungs with small lymphocytes occurs in transgenic mice; however, inflammation is minimal
• spleens of transgenic mice become enlarged, with marked infiltration by small lymphocytes
• lymph nodes of transgenic mice become enlarged, with marked infiltration by small lymphocytes

hematopoietic system
• by 12-24 weeks of age, CD8+ numbers begin to rise in transgenic mice such that eventually cells from the spleen and lymph nodes (LN) of transgenic mice contain up to 10-fold the numbers of CD8+ T cells seen in splenocytes and LN cells of control mice, whereas absolute numbers of splenic and LN CD4+ T cells and of B cells in transgenic mice are similar to or lower than in control mice
• the CD4+/CD8+ T cell ratio of transgenic mice between 12 and 24 weeks of age becomes severely skewed in favor of CD8+ T cells due to the expansion of CD8+ cells
• a significantly higher proportion of lymph node T cells is cycling in transgenic than in littermate control mice
• the proportion of peripheral CD8+ T cells that are acively cycling in transgenic mice reaches the level (5-8%) seen in thymi of both transgenic and wild-type mice
• over time, the expanded CD8+ T cell population in transgenic mice progresses from polyclonal to oligoclonal - representing several clonal lineages - to, by 6-12 months of age, monoclonal or biclonal, based on the T cell beta variable region (TCR-Vb) repertoire of the population
• moderate infiltration of the heart, liver and lungs with small lymphocytes occurs in transgenic mice; however, inflammation is minimal
• spleens of transgenic mice become enlarged, with marked infiltration by small lymphocytes

cellular
• by 12-24 weeks of age, CD8+ numbers begin to rise in transgenic mice such that eventually cells from the spleen and lymph nodes (LN) of transgenic mice contain up to 10-fold the numbers of CD8+ T cells seen in splenocytes and LN cells of control mice, whereas absolute numbers of splenic and LN CD4+ T cells and of B cells in transgenic mice are similar to or lower than in control mice
• the CD4+/CD8+ T cell ratio of transgenic mice between 12 and 24 weeks of age becomes severely skewed in favor of CD8+ T cells due to the expansion of CD8+ cells
• a significantly higher proportion of lymph node T cells is cycling in transgenic than in littermate control mice
• the proportion of peripheral CD8+ T cells that are acively cycling in transgenic mice reaches the level (5-8%) seen in thymi of both transgenic and wild-type mice
• over time, the expanded CD8+ T cell population in transgenic mice progresses from polyclonal to oligoclonal - representing several clonal lineages - to, by 6-12 months of age, monoclonal or biclonal, based on the T cell beta variable region (TCR-Vb) repertoire of the population
• moderate infiltration of the heart, liver and lungs with small lymphocytes occurs in transgenic mice; however, inflammation is minimal

growth/size/body
• spleens of transgenic mice become enlarged, with marked infiltration by small lymphocytes


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/18/2025
MGI 6.24
The Jackson Laboratory